HONG KONG (Reuters) – Chinese biotech firm Innovent Biologics 1801.HK priced its Hong Kong initial public offering near the top of an indicative range, raising $421 million in the city’s largest biote…
( read original story …)
The HongKong News
HONG KONG (Reuters) – Chinese biotech firm Innovent Biologics 1801.HK priced its Hong Kong initial public offering near the top of an indicative range, raising $421 million in the city’s largest biote…
( read original story …)